BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress

Tharu M. Fernando, Rossella Marullo, Benet Pera Gresely, Jude M. Phillip, Shao Ning Yang, Geoffrey Lundell-Smith, Ingrid Torregroza, Haelee Ahn, Todd Evans, B. Györffy, Gilbert G. Privé, Masayuki Hirano, Ari M. Melnick, Leandro Cerchietti

Research output: Contribution to journalArticle

Abstract

Several lines of evidence link the canonical oncogene BCL6 to stress response. Here we demonstrate that BCL6 evolved in vertebrates as a component of the HSF1-driven stress response, which has been co-opted by the immune system to support germinal center formation and may have been decisive in the convergent evolution of humoral immunity in jawless and jawed vertebrates. We find that the highly conserved BTB corepressor binding site of BCL6 mediates stress adaptation across vertebrates. We demonstrate that pan-cancer cells hijack this stress tolerance mechanism to aberrantly express BCL6. Targeting the BCL6 BTB domain in cancer cells induces apoptosis and increases susceptibility to repeated doses of cytotoxic therapy. The chemosensitization effect upon BCL6 BTB inhibition is dependent on the derepression of TOX, implicating modulation of DNA repair as a downstream mechanism. Collectively, these data suggest a form of adaptive nononcogene addiction rooted in the natural selection of BCL6 during vertebrate evolution. SIGNIFICANCE: We demonstrate that HSF1 drives BCL6 expression to enable stress tolerance in vertebrates. We identify an HSF1-BCL6-TOX stress axis that is required by cancer cells to tolerate exposure to cytotoxic agents and points toward BCL6-targeted therapy as a way to more effectively kill a wide variety of solid tumors.This article is highlighted in the In This Issue feature, p. 565.

Original languageEnglish
Pages (from-to)662-679
Number of pages18
JournalCancer discovery
Volume9
Issue number5
DOIs
Publication statusPublished - May 1 2019

Fingerprint

Vertebrates
Neoplasms
Co-Repressor Proteins
Germinal Center
Genetic Selection
Cytotoxins
Humoral Immunity
Oncogenes
DNA Repair
Immune System
Binding Sites
Apoptosis
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Fernando, T. M., Marullo, R., Pera Gresely, B., Phillip, J. M., Yang, S. N., Lundell-Smith, G., ... Cerchietti, L. (2019). BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress. Cancer discovery, 9(5), 662-679. https://doi.org/10.1158/2159-8290.CD-17-1444

BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress. / Fernando, Tharu M.; Marullo, Rossella; Pera Gresely, Benet; Phillip, Jude M.; Yang, Shao Ning; Lundell-Smith, Geoffrey; Torregroza, Ingrid; Ahn, Haelee; Evans, Todd; Györffy, B.; Privé, Gilbert G.; Hirano, Masayuki; Melnick, Ari M.; Cerchietti, Leandro.

In: Cancer discovery, Vol. 9, No. 5, 01.05.2019, p. 662-679.

Research output: Contribution to journalArticle

Fernando, TM, Marullo, R, Pera Gresely, B, Phillip, JM, Yang, SN, Lundell-Smith, G, Torregroza, I, Ahn, H, Evans, T, Györffy, B, Privé, GG, Hirano, M, Melnick, AM & Cerchietti, L 2019, 'BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress', Cancer discovery, vol. 9, no. 5, pp. 662-679. https://doi.org/10.1158/2159-8290.CD-17-1444
Fernando, Tharu M. ; Marullo, Rossella ; Pera Gresely, Benet ; Phillip, Jude M. ; Yang, Shao Ning ; Lundell-Smith, Geoffrey ; Torregroza, Ingrid ; Ahn, Haelee ; Evans, Todd ; Györffy, B. ; Privé, Gilbert G. ; Hirano, Masayuki ; Melnick, Ari M. ; Cerchietti, Leandro. / BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress. In: Cancer discovery. 2019 ; Vol. 9, No. 5. pp. 662-679.
@article{4517e804650445ff82f2d1815de2b56d,
title = "BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress",
abstract = "Several lines of evidence link the canonical oncogene BCL6 to stress response. Here we demonstrate that BCL6 evolved in vertebrates as a component of the HSF1-driven stress response, which has been co-opted by the immune system to support germinal center formation and may have been decisive in the convergent evolution of humoral immunity in jawless and jawed vertebrates. We find that the highly conserved BTB corepressor binding site of BCL6 mediates stress adaptation across vertebrates. We demonstrate that pan-cancer cells hijack this stress tolerance mechanism to aberrantly express BCL6. Targeting the BCL6 BTB domain in cancer cells induces apoptosis and increases susceptibility to repeated doses of cytotoxic therapy. The chemosensitization effect upon BCL6 BTB inhibition is dependent on the derepression of TOX, implicating modulation of DNA repair as a downstream mechanism. Collectively, these data suggest a form of adaptive nononcogene addiction rooted in the natural selection of BCL6 during vertebrate evolution. SIGNIFICANCE: We demonstrate that HSF1 drives BCL6 expression to enable stress tolerance in vertebrates. We identify an HSF1-BCL6-TOX stress axis that is required by cancer cells to tolerate exposure to cytotoxic agents and points toward BCL6-targeted therapy as a way to more effectively kill a wide variety of solid tumors.This article is highlighted in the In This Issue feature, p. 565.",
author = "Fernando, {Tharu M.} and Rossella Marullo and {Pera Gresely}, Benet and Phillip, {Jude M.} and Yang, {Shao Ning} and Geoffrey Lundell-Smith and Ingrid Torregroza and Haelee Ahn and Todd Evans and B. Gy{\"o}rffy and Priv{\'e}, {Gilbert G.} and Masayuki Hirano and Melnick, {Ari M.} and Leandro Cerchietti",
year = "2019",
month = "5",
day = "1",
doi = "10.1158/2159-8290.CD-17-1444",
language = "English",
volume = "9",
pages = "662--679",
journal = "Cancer Discovery",
issn = "2159-8274",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to Stress

AU - Fernando, Tharu M.

AU - Marullo, Rossella

AU - Pera Gresely, Benet

AU - Phillip, Jude M.

AU - Yang, Shao Ning

AU - Lundell-Smith, Geoffrey

AU - Torregroza, Ingrid

AU - Ahn, Haelee

AU - Evans, Todd

AU - Györffy, B.

AU - Privé, Gilbert G.

AU - Hirano, Masayuki

AU - Melnick, Ari M.

AU - Cerchietti, Leandro

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Several lines of evidence link the canonical oncogene BCL6 to stress response. Here we demonstrate that BCL6 evolved in vertebrates as a component of the HSF1-driven stress response, which has been co-opted by the immune system to support germinal center formation and may have been decisive in the convergent evolution of humoral immunity in jawless and jawed vertebrates. We find that the highly conserved BTB corepressor binding site of BCL6 mediates stress adaptation across vertebrates. We demonstrate that pan-cancer cells hijack this stress tolerance mechanism to aberrantly express BCL6. Targeting the BCL6 BTB domain in cancer cells induces apoptosis and increases susceptibility to repeated doses of cytotoxic therapy. The chemosensitization effect upon BCL6 BTB inhibition is dependent on the derepression of TOX, implicating modulation of DNA repair as a downstream mechanism. Collectively, these data suggest a form of adaptive nononcogene addiction rooted in the natural selection of BCL6 during vertebrate evolution. SIGNIFICANCE: We demonstrate that HSF1 drives BCL6 expression to enable stress tolerance in vertebrates. We identify an HSF1-BCL6-TOX stress axis that is required by cancer cells to tolerate exposure to cytotoxic agents and points toward BCL6-targeted therapy as a way to more effectively kill a wide variety of solid tumors.This article is highlighted in the In This Issue feature, p. 565.

AB - Several lines of evidence link the canonical oncogene BCL6 to stress response. Here we demonstrate that BCL6 evolved in vertebrates as a component of the HSF1-driven stress response, which has been co-opted by the immune system to support germinal center formation and may have been decisive in the convergent evolution of humoral immunity in jawless and jawed vertebrates. We find that the highly conserved BTB corepressor binding site of BCL6 mediates stress adaptation across vertebrates. We demonstrate that pan-cancer cells hijack this stress tolerance mechanism to aberrantly express BCL6. Targeting the BCL6 BTB domain in cancer cells induces apoptosis and increases susceptibility to repeated doses of cytotoxic therapy. The chemosensitization effect upon BCL6 BTB inhibition is dependent on the derepression of TOX, implicating modulation of DNA repair as a downstream mechanism. Collectively, these data suggest a form of adaptive nononcogene addiction rooted in the natural selection of BCL6 during vertebrate evolution. SIGNIFICANCE: We demonstrate that HSF1 drives BCL6 expression to enable stress tolerance in vertebrates. We identify an HSF1-BCL6-TOX stress axis that is required by cancer cells to tolerate exposure to cytotoxic agents and points toward BCL6-targeted therapy as a way to more effectively kill a wide variety of solid tumors.This article is highlighted in the In This Issue feature, p. 565.

UR - http://www.scopus.com/inward/record.url?scp=85065510862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065510862&partnerID=8YFLogxK

U2 - 10.1158/2159-8290.CD-17-1444

DO - 10.1158/2159-8290.CD-17-1444

M3 - Article

C2 - 30777872

AN - SCOPUS:85065510862

VL - 9

SP - 662

EP - 679

JO - Cancer Discovery

JF - Cancer Discovery

SN - 2159-8274

IS - 5

ER -